Quantitative Results of Perfusion Utilising Hyperspectral Imaging on Non-diabetics and Diabetics: A Pilot Study.
There is a paucity of quantitative measures of microvascular perfusion values in the skin. Newly developed, handheld hyperspectral imaging devices identify unique spectral fingerprints of oxygenated and deoxygenated haemoglobin in the superficial microvasculature. Establishing value ranges for healthy patients without vascular complications will subsequently help standardise assessments for perfusion defects. In particular, diabetics who are prone to vascular calcifications and lower extremity wounds may benefit. A total of 73 subjects were enrolled in the study and split in two cohorts: 36 'non-diabetic' non-vascularly compromised patients and 37 'diabetic' patients with a formal diagnosis of diabetes but without history of pedal ulceration. Values of oxygenated haemoglobin (HT-Oxy) and deoxygenated haemoglobin (HT-DeOxy) from both devices are analysed.
['Lee|Christina J|CJ|', 'Walters|Elliot|E|', 'Kennedy|Christopher J|CJ|', 'Beitollahi|Ariya|A|', 'Evans|Karen K|KK|', 'Attinger|Christopher E|CE|', 'Kim|Paul J|PJ|']
D003920:Diabetes Mellitus D006801:Humans D000081862:Hyperspectral Imaging D010477:Perfusion D010865:Pilot Projects D012867:Skin
hyperspectral imaging haemoglobin microvasculature perfusion assessment tissue oxygenation